MA Research Update — July 17, 2026
Updated Thesis
Mastercard operates a global two-sided payments network that connects issuers, acquirers, merchants and cardholders, monetizing payment volumes and an expanding set of security, data, authentication and other value-added services. Business quality is high: the network benefits from powerful acceptance and scale effects, 83.0% gross margin, 59.4% operating margin, 45.9% net margin, 206.1% ROE, and revenue and earnings growth of 15.8% and 18.4%, respectively, in the most recent quarter. At $543.60, the shares trade at 31.42x trailing earnings, 14.15x sales, 27.11x free cash flow and 23.27x EV/EBITDA, which remains a premium absolute valuation but is classified as cheap versus the company’s five-year historical regime.
The investment grade as of this refresh is A — high business quality. A-tier business, B-tier valuation, with 45.0% upside to $788.22 fair value and a near-term Q2 2026 earnings catalyst.
Grade Change
In this research cycle, the investment grade for Mastercard Incorporated moved from B to A. A-tier business, B-tier valuation, with 45.0% upside to $788.22 fair value and a near-term Q2 2026 earnings catalyst.
Key Metrics at a Glance
- Revenue growth: +15.8% year over year
- Net margin: 45.9%
- Fair value upside: +45.0% to our estimate of $788
Current price: $543.60
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Mastercard Incorporated remains in our covered universe with a high-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full MA research →](/stocks/MA)